ArticleChemistryOpen2025
A Facile Method to Incorporate Di-Dopant Elements (F and Sb) into Crystalline Mesoporous Tin Dioxide Nano Powder at Ambient Temperature and Pressure.
Article in ChemistryOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
A simple two step synthetic method for di-doped crystalline mesoporous tin dioxide powder containing antimony and fluoride at ambient pressure and temperature has been developed. This approach produced materials with high surface areas and improved electrical and optoelectrical conductance. The two dopant elements; antimony and fluoride were introduced to tin dioxide by two approaches. Both approaches produced mesoporous tin dioxide with antimony and fluoride that are integrated in the framework. The structures of these materials are analyzed by powder X-ray diffraction, N
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.